Presentation is loading. Please wait.

Presentation is loading. Please wait.

Erin M. Schumer, MD, MPH, Matthew C

Published byבַּעַל־זְבוּל Βέργας Modified over 6 years ago

Similar presentations

Presentation on theme: "Erin M. Schumer, MD, MPH, Matthew C"— Presentation transcript:

1 Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection 
Erin M. Schumer, MD, MPH, Matthew C. Black, MD, Michael Bousamra, MD, Jaimin R. Trivedi, MD, MPH, Mingxiao Li, PhD, Xiao-An Fu, PhD, Victor van Berkel, MD, PhD  The Annals of Thoracic Surgery  Volume 102, Issue 4, Pages (October 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Median concentrations for carbonyl compounds before and after resection in patients who underwent lung transplantation compared with median control values. Error bars represent 95% confidence interval. Concentrations are in nmol/L. *p < (4-HHE = 4-hydroxyhexanal.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Values for 2-butanone, 3-hydroxy-2-butanone, 2-hydroxyacetaldehyde, and 4-hydroxyhexanal (4-HHE) before and after resection when the value before resection is elevated. The dashed line is the threshold for an elevated carbonyl compound. Concentrations are in nmol/L. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Erin M. Schumer, MD, MPH, Matthew C"

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
What Predicts Long-Term Survival After Heart Transplantation

What Predicts Long-Term Survival After Heart Transplantation
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M

Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Burdens Without Blessings: Peer Reviewers Get No Respect

Burdens Without Blessings: Peer Reviewers Get No Respect
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease  Michael Bousamra, MD, Erin Schumer, MS, MD,

Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease  Michael Bousamra, MD, Erin Schumer, MS, MD,
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Similar presentations

Ads by Google